Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon.

Abou Ali B, Salman M, Ghanem KM, Boulos F, Haidar R, Saghieh S, Akel S, Muwakkit SA, El-Solh H, Saab R, Tamim H, Abboud MR.

J Glob Oncol. 2019 Apr;5:1-8. doi: 10.1200/JGO.17.00241.

2.

Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study.

Zgheib NK, Ghanem KM, Tamim H, Aridi C, Shahine R, Tarek N, Saab R, Abboud MR, El-Solh H, Muwakkit SA.

Pharmacogenet Genomics. 2018 Aug;28(8):189-195. doi: 10.1097/FPC.0000000000000345.

PMID:
30119132
3.

Displaced children with cancer in Lebanon: A sustained response to an unprecedented crisis.

Saab R, Jeha S, Khalifeh H, Zahreddine L, Bayram L, Merabi Z, Abboud M, Muwakkit S, Tarek N, Rodriguez-Galindo C, El Solh H.

Cancer. 2018 Apr 1;124(7):1464-1472. doi: 10.1002/cncr.31273. Epub 2018 Feb 28.

4.

Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia.

Ghanem KM, Kharfan-Dabaja MA, El-Solh H, Harris N, Kreidieh N, Nehme R, Muwakkit SA, Saab R, Bazarbachi A, Abboud MR.

Curr Res Transl Med. 2017 Sep;65(3):115-119. doi: 10.1016/j.retram.2017.09.001. Epub 2017 Oct 4.

PMID:
28988743
5.

Routine surveillance imaging after end of therapy for pediatric extracranial tumors: A retrospective analysis.

Lakkis F, Alaiwi SA, Naffaa L, Atweh L, Khoury N, Abboud M, Muwakkit S, Tarek N, El Solh H, Saab R.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26723. Epub 2017 Jul 20.

PMID:
28727257
6.

Pediatric cancer pathology review from a single institution: Neuropathology expert opinion is essential for accurate diagnosis of pediatric brain tumors.

Merabi Z, Boulos F, Santiago T, Jenkins J, Abboud M, Muwakkit S, Tarek N, Zaatari G, Jeha S, El-Solh H, Saab R.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26709. Epub 2017 Jul 4.

PMID:
28675683
7.

Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management.

Ghanem KM, Dhayni RM, Al-Aridi C, Tarek N, Tamim H, Chan AKC, Saab R, Abboud MR, El-Solh H, Muwakkit SA.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26694. Epub 2017 Jun 29.

PMID:
28660695
8.

Vesicoileal fistula and Clostridium difficile colitis in a child with acute lymphoblastic leukemia.

Alainawi M, Shaker R, Eltraboulsi A, Akel S, Yazbeck N, El Solh H, Muwakkit S.

Hematol Oncol Stem Cell Ther. 2017 Jun;10(2):93-95. doi: 10.1016/j.hemonc.2016.10.001. Epub 2016 Nov 9. No abstract available.

9.

First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group.

Hussein AA, Hamidieh AA, Elhaddad A, Ramzi M, Othman TB, Hussain F, Dennison D, Ahmed P, Abboud M, Al-Ahmari A, Wahadneh A, Fathy J, Bekadja MA, Al-Kindi S, Benchekroun S, Ibrahim A, Behfar M, Samra M, Ladeb S, Adil S, El-Solh H, Ayas M, Aljurf M, Ghavamzadeh A, Al-Seraihy A; Pediatric Cancer Working Committee of the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group.

Bone Marrow Transplant. 2017 Jan;52(1):120-125. doi: 10.1038/bmt.2016.209. Epub 2016 Sep 12.

PMID:
27618684
10.

NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.

Zgheib NK, Akika R, Mahfouz R, Aridi CA, Ghanem KM, Saab R, Abboud MR, Tarek N, El Solh H, Muwakkit SA.

Pediatr Blood Cancer. 2017 Jan;64(1):146-150. doi: 10.1002/pbc.26189. Epub 2016 Aug 31.

PMID:
27577869
11.

Collaborative Pediatric Bone Tumor Program to Improve Access to Specialized Care: An Initiative by the Lebanese Children's Oncology Group.

Saab R, Merabi Z, Abboud MR, Muwakkit S, Noun P, Gemayel G, Bechara E, Khalifeh H, Farah R, Kabbara N, El-Khoury T, Al-Yousef R, Haidar R, Saghieh S, Eid T, Akel S, Khoury N, Bayram L, Krasin MJ, Jeha S, El-Solh H.

J Glob Oncol. 2016 May 18;3(1):23-30. doi: 10.1200/JGO.2016.003103. eCollection 2017 Feb.

12.

Chimerism Analysis of Cell-Free DNA in Patients Treated with Hematopoietic Stem Cell Transplantation May Predict Early Relapse in Patients with Hematologic Malignancies.

Aljurf M, Abalkhail H, Alseraihy A, Mohamed SY, Ayas M, Alsharif F, Alzahrani H, Al-Jefri A, Aldawsari G, Al-Ahmari A, Belgaumi AF, Walter CU, El-Solh H, Rasheed W, Albitar M.

Biotechnol Res Int. 2016;2016:8589270. doi: 10.1155/2016/8589270. Epub 2016 Feb 23.

13.

The contribution of multiple packed red blood cell transfusions toward cardiac and liver dysfunction in pediatric patients with acute myeloid leukemia.

Al-Darwish M, Farhan N, Al-Jebreen A, Allam R, Al-Ahmari A, Seraihy A, Al-Sweedan S, El-Solh H, Belgaumi AF.

Leuk Lymphoma. 2016 Oct;57(10):2472-5. doi: 10.3109/10428194.2016.1151509. Epub 2016 Feb 25. No abstract available.

PMID:
26916606
14.

Wilms tumor: Successes and challenges in management outside of cooperative clinical trials.

Rabeh W, Akel S, Eid T, Muwakkit S, Abboud M, El Solh H, Saab R.

Hematol Oncol Stem Cell Ther. 2016 Mar;9(1):20-5. doi: 10.1016/j.hemonc.2015.12.006. Epub 2016 Jan 18.

15.

Outcome of pediatric patients with lymphoma following stem cell transplant: a single institution report.

Sumaili H, Al-Kofide A, Al-Seraihi A, Ayas M, Siddiqui K, El-Solh H, Al-Jefri A, Al-Ahmari A, Mohamed A, Anas M, Belgaumi AF.

Leuk Lymphoma. 2015 May;56(5):1327-34. doi: 10.3109/10428194.2014.951846. Epub 2014 Oct 9.

PMID:
25139691
16.

Factors affecting the outcome of related allogeneic hematopoietic cell transplantation in patients with Fanconi Anemia.

Ayas M, Siddiqui K, Al-Jefri A, El-Solh H, Al-Ahmari A, Khairy A, Markiz S, Shahin H, Al-Musa A, Al-Seraihy A.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1599-603. doi: 10.1016/j.bbmt.2014.06.016. Epub 2014 Jun 21.

17.

Outcome of Ewing sarcoma in a multidisciplinary setting in Lebanon.

Abou Ali B, Nader R, Tamim H, Eid T, Boulos F, Khoury N, Akel S, Haidar R, Saghieh S, Abboud M, Muwakkit S, El-Solh H, Saab R.

Pediatr Blood Cancer. 2014 Aug;61(8):1472-5. doi: 10.1002/pbc.24926. Epub 2014 Jan 7.

PMID:
24395458
18.

Cytomegalovirus retinitis in children and young adults with acute lymphoblastic leukemia in Lebanon.

Samia L, Hamam R, Dbaibo G, Saab R, El-Solh H, Abboud M, Muwakkit S.

Leuk Lymphoma. 2014 Aug;55(8):1918-21. doi: 10.3109/10428194.2013.854887. Epub 2014 Feb 4. No abstract available.

PMID:
24138305
19.

Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution.

Farhat R, Raad R, Khoury NJ, Feghaly J, Eid T, Muwakkit S, Abboud M, El-Solh H, Saab R.

J Pediatr Hematol Oncol. 2013 Jul;35(5):356-60. doi: 10.1097/MPH.0b013e318270a343.

PMID:
23042020
20.

Outcome of risk adapted therapy for relapsed/refractory acute lymphoblastic leukemia in children.

Belgaumi AF, Al-Seraihy A, Siddiqui KS, Ayas M, Bukhari A, Al-Musa A, Al-Ahmari A, El-Solh H.

Leuk Lymphoma. 2013 Mar;54(3):547-54. doi: 10.3109/10428194.2012.719616. Epub 2012 Oct 18.

PMID:
22938053
21.

Outcome of allogeneic stem cell transplantation with a conditioning regimen of busulfan, cyclophosphamide and low-dose etoposide for children with myelodysplastic syndrome.

Al-Seraihy A, Ayas M, Al-Nounou R, El-Solh H, Al-Ahmari A, Al-Jefri A, Belgaumi A.

Hematol Oncol Stem Cell Ther. 2011;4(3):121-5.

22.

The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.

Ayas M, Al-Seraihi A, El-Solh H, Al-Ahmari A, Khairy A, Aldali A, Markiz S, Siddiqui K, Al-Jefri A.

Biol Blood Marrow Transplant. 2012 Apr;18(4):627-32. doi: 10.1016/j.bbmt.2011.08.015. Epub 2011 Aug 24.

23.

Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes.

Al-Hajjar S, Al Seraihi A, Al Muhsen S, Ayas M, Al Jumaah S, Al Jefri A, Shoukri M, El Solh H.

Hematol Oncol Stem Cell Ther. 2011;4(2):67-72.

24.

Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.

Ahmed SO, Ghavamzadeh A, Zaidi SZ, Baldomero H, Pasquini MC, Hussain F, Alimoghaddam K, Almohareb F, Ayas M, Hamidieh A, Mahmoud HK, Elhaddad A, Ben Othman T, Abdelkefi A, Sarhan M, Abdel-Rahman F, Adil S, Alkindi S, Bazarbachi A, Benchekroun S, Niederwieser D, Horowitz M, Gratwohl A, El Solh H, Aljurf M.

Biol Blood Marrow Transplant. 2011 Sep;17(9):1352-61. doi: 10.1016/j.bbmt.2011.01.019. Epub 2011 Apr 1.

25.

Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type 1: a single center experience.

Al-Dhekri H, Al-Mousa H, Ayas M, Al-Muhsen S, Al-Ghonaium A, Al-Ghanam G, Al-Saud B, Arnaout R, Al-Seraihy A, Al-Ahmari A, Al-Jefri A, Al-Mahr M, El-Solh H.

Biol Blood Marrow Transplant. 2011 Aug;17(8):1245-9. doi: 10.1016/j.bbmt.2010.12.714. Epub 2011 Jan 8.

26.

Outcome of second allogenic stem cell transplantation in pediatric patients with non-malignant hematological and immune deficiency disorders.

Ayas M, Al-Jefri A, Eldali A, Al-Seraihi A, Al-Mahr M, Al-Ghonaium A, Al-Ahmari A, Al-Muhsen S, Al-Mousa H, Al-Dhekri H, Al-Saud B, El-Solh H.

Pediatr Blood Cancer. 2011 Feb;56(2):289-93. doi: 10.1002/pbc.22804. Epub 2010 Oct 22.

PMID:
21157896
27.

Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia.

Belgaumi AF, Al-Shehri A, Ayas M, Al-Mahr M, Al-Seraihy A, Al-Ahmari A, El-Solh H.

Haematologica. 2010 Jul;95(7):1211-5. doi: 10.3324/haematol.2009.015180. Epub 2010 Apr 21.

28.

Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO).

Aljurf M, Zaidi SZ, Hussain F, Ghavamzadeh A, Alimoghaddam K, Jahani M, Mahmoud HK, Haddad A, Adil S, Ben Othman T, Sarhan MM, Dennison D, Ibrahim A, Benchekroun S, Ayas M, Al Zahrani H, Al Mohareb F, El Solh H.

Transfus Apher Sci. 2010 Apr;42(2):169-75. doi: 10.1016/j.transci.2010.01.012. Epub 2010 Jan 27.

PMID:
20110194
29.

Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.

Al-Mousa H, Al-Shammari Z, Al-Ghonaium A, Al-Dhekri H, Al-Muhsen S, Al-Saud B, Arnaout R, Al-Seraihy A, Al-Jefri A, Al-Ahmari A, Ayas M, El-Solh H.

Biol Blood Marrow Transplant. 2010 Jun;16(6):818-23. doi: 10.1016/j.bbmt.2010.01.002. Epub 2010 Jan 14.

30.

Hematopoietic SCT in children with Griscelli syndrome: a single-center experience.

Al-Ahmari A, Al-Ghonaium A, Al-Mansoori M, Hawwari A, Eldali A, Ayas M, Al-Mousa H, Al-Jefri A, Al-Saud B, Al-Seraihy A, Al-Muhsen S, Al-Mahr M, Al-Dhekri H, El-Solh H.

Bone Marrow Transplant. 2010 Aug;45(8):1294-9. doi: 10.1038/bmt.2009.358. Epub 2010 Jan 11.

PMID:
20062095
31.

Unrelated cord blood transplantation in pediatric patients: a report from Saudi Arabia.

Ayas M, Al-Seraihi A, Al-Jefri A, Al-Ahmari A, Al-Mahr M, Al-Ghonaium A, Al-Muhsen S, Al-Mousa H, Al-Dhekri H, Alsaud B, Eldali A, Mohamad A, Al-Humaidan H, Chadrawi A, Al-Kaff M, Al-Hassnan Z, El-Solh H.

Bone Marrow Transplant. 2010 Aug;45(8):1281-6. doi: 10.1038/bmt.2009.350. Epub 2009 Dec 14.

PMID:
20010867
32.

Allogeneic stem cell transplantation in patients with β-thalassemia: King Faisal specialist hospital and research centre experience.

Al-Jefri A, Ayas A, Al Musa A, Al Mahr M, Al Saleh M, Rifai S, Sabbah R, Al Seraihy A, Al Ahmari A, Khairy E, Al Hassan I, El Solh H.

Hemoglobin. 2009;33 Suppl 1:S183-7. doi: 10.3109/03630260903351841.

PMID:
20001624
33.

Clinical characteristics and outcome of children with biphenotypic acute leukemia.

Al-Seraihy AS, Owaidah TM, Ayas M, El-Solh H, Al-Mahr M, Al-Ahmari A, Belgaumi AF.

Haematologica. 2009 Dec;94(12):1682-90. doi: 10.3324/haematol.2009.009282. Epub 2009 Aug 27.

34.

Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report.

Aljurf MD, Zaidi SZ, El Solh H, Hussain F, Ghavamzadeh A, Mahmoud HK, Shamsi T, Othman TB, Sarhan MM, Dennison D, Ibrahim A, Benchekroun S, Chaudhri N, Labar B, Horowitz M, Niederwieser D, Gratwohl A.

Bone Marrow Transplant. 2009 Jan;43(1):1-12. doi: 10.1038/bmt.2008.389. Epub 2008 Dec 1.

35.

Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 year's experience.

Ayas M, Al-Jefri A, Al-Seraihi A, Elkum N, Al-Mahr M, El-Solh H.

Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S45-S48. doi: 10.1038/bmt.2008.114.

PMID:
18724300
36.

Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience.

Al-Nasser A, El-Solh H, De Vol E, El-Hassan I, Alzahrani A, Al-Sudairy R, Al-Mahr M, Al-Musa A, Al-Jefri A, Saleh M, Rifai S, Belgaumi A, Osman L, Ashraf K, Salim M, Silo A, Roberts G.

Ann Saudi Med. 2008 Jul-Aug;28(4):251-9.

37.

Second stem cell transplantation in patients with Fanconi anemia using antithymocyte globulin alone for conditioning.

Ayas M, Al-Jefri A, Al-Seraihi A, Al-Mahr M, Al-Ahmari A, El-Solh H.

Biol Blood Marrow Transplant. 2008 Apr;14(4):445-8. doi: 10.1016/j.bbmt.2008.02.004.

38.

Allogeneic stem cell transplantation in Fanconi anemia patients presenting with myelodysplasia and/or clonal abnormality: update on the Saudi experience.

Ayas M, Al-Jefri A, Al-Seraihi A, Al-Mahr M, Rifai S, Al-Ahmari A, Khairy A, El-Hassan I, El-Solh H.

Bone Marrow Transplant. 2008 Feb;41(3):261-5. Epub 2007 Nov 5.

PMID:
17982499
39.

Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.

Siraj AK, Ibrahim M, Al-Rasheed M, Bu R, Bavi P, Jehan Z, Abubaker J, Murad W, Al-Dayel F, Ezzat A, El-Solh H, Uddin S, Al-Kuraya K.

Ann Hematol. 2007 Dec;86(12):887-95. Epub 2007 Aug 22.

PMID:
17712558
40.

Invasive chaetomium infection in two immunocompromised pediatric patients.

Al-Aidaroos A, Bin-Hussain I, El Solh H, Kofide A, Thawadi S, Belgaumi A, Al Ahmari A.

Pediatr Infect Dis J. 2007 May;26(5):456-8. Review.

PMID:
17468664
41.

Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.

Bavi P, Jehan Z, Atizado V, Al-Dossari H, Al-Dayel F, Tulbah A, Amr SS, Sheikh SS, Ezzat A, El-Solh H, Uddin S, Al-Kuraya K.

Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1708-18.

42.

Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival.

Uddin S, Hussain AR, Siraj AK, Manogaran PS, Al-Jomah NA, Moorji A, Atizado V, Al-Dayel F, Belgaumi A, El-Solh H, Ezzat A, Bavi P, Al-Kuraya KS.

Blood. 2006 Dec 15;108(13):4178-86. Epub 2006 Aug 31.

PMID:
16946303
43.

High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle East.

Al-Kuraya K, Narayanappa R, Siraj AK, Al-Dayel F, Ezzat A, El Solh H, Al-Jommah N, Sauter G, Simon R.

Hum Pathol. 2006 Jun;37(6):742-8.

PMID:
16733216
44.

High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi Arabia.

Al Kuraya K, Siraj AK, Bavi P, Al-Jomah N, El-Solh H, Ezzat A, Al-Dayel F, Belgaumi A, Al-Kofide A, Sabbah R, Sheikh S, Amr S, Simon R, Sauter G.

Mod Pathol. 2006 Aug;19(8):1124-9. Epub 2006 May 19.

45.

Epstein-Barr virus infection is not the sole cause of high prevalence for Hodgkin's lymphoma in Saudi Arabia.

Al-Kuraya K, Narayanappa R, Al-Dayel F, El-Solh H, Ezzat A, Ismail H, Belgaumi A, Bavi P, Atizado V, Sauter G, Simon R.

Leuk Lymphoma. 2006 Apr;47(4):707-13.

PMID:
16690530
46.

The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen.

Ayas M, Al-Seraihi A, Al-Mahr M, Al-Jefri A, Belgaumi A, Elhassan I, El-Solh H.

Pediatr Blood Cancer. 2006 Dec;47(7):926-30.

PMID:
16425264
47.

Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulin.

Ayas M, Al-Musa A, Al-Jefri A, Al-Seraihi A, Al-Mahr M, Rifai S, El-Solh H.

Pediatr Blood Cancer. 2007 Jul;49(1):103-4.

PMID:
16317729
48.

Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy.

Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, Al-Seraihi A, Tbakhi A, Mustafa M, Khairy A, Moussa E, Iqbal A, Shalaby L, El-Solh H.

Bone Marrow Transplant. 2005 Mar;35(5):463-6.

PMID:
15654354
49.

Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.

Al-Qurashi F, Ayas M, Al Sharif F, Ibrahim E, Sahovic E, Al Mahr M, Chaudhri N, Al Mohareb F, Al Zahrani H, Al Jefri A, Al Omar H, Al Shanqeeti A, Seth P, Aslam M, El Solh H, Aljurf M.

Hematology. 2004 Apr;9(2):123-9.

PMID:
15203867
50.

Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT).

Al-Ahmari A, Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, El-Solh H.

Bone Marrow Transplant. 2004 Apr;33(8):829-31.

PMID:
14968137

Supplemental Content

Loading ...
Support Center